(Business Wire India); Brickwork India, the India representative of Fairfax County Economic Development Authority (FCEDA) organized the seminar on Global Expansion in Bangalore on July 23rd 2015. The seminar, conducted with the Indo-American Chamber of Commerce (IACC), highlighted the business opportunities in Fairfax County, Virginia – just outside Washington, DC – for Indian firms with IT services and solutions for the Cloud Computing, Big Data Analytics and Defence and Aerospace domains.
~ Through the acquisition of InvaGen, Cipla gains scale in the US generics market with a strong manufacturing and R&D base, access to broad product portfolio and a strong customer base consisting of top wholesalers/retailers
~ Through the acquisition of Exelan, Cipla gains access to the government and institutional market in the US
Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc. The transaction being subject to certain closing conditions, is valued at $550 million and will be an all cash transaction. The combined revenue from these transactions is over $200 million for the year ended Dec 2014 and over $225 million in LTM June 2015.


